Fee-for-service healthcare makes it difficult for people with T1D to access the care, education, and support that they need. As a result, only 1 in 4 adults with T1D in the US achieve recommended blood glucose levels (A1C < 7) despite an average of $19,000 per person per year and $29,000 average cost for each DKA admission.
Blue Circle Health (BCH) is a clinical care, education, and support program designed to close this gap. The program is delivered remotely, is 6 months long, and includes coordinated services of endocrinology, peer support, diabetes counseling, case management, insurance navigation, and education. It also includes a CGM trial program that provides 3 months of free CGMs with education and financial support for medications. Importantly, because the services are funded, they are free to the participants, allowing the design to be based solely on what’s best for patients as opposed to what’s reimbursed. This has led to a team-based clinical care model focused on identifying and addressing individual patient needs with the goal of empowering each participant.
In this session, we present an analysis of the first 57 patients that completed the program and responded to the voluntary T1-DDAS survey on completion. Authors: Monica A. Gomberg, MD, Blue Circle Health; Colin Mullaney, BS, Blue Circle Health; Megan E. Buhler, M.Ed., Blue Circle Health; Kira Chaney, MPH, Blue Circle Health; Kathryn Ward, LCSW, Blue Circle Health Sarah C. Westen, Ph.D., University of Florida, Blue Circle Health; Leonard W. D’Avolio, PhD, Harvard Medical School, Massachusetts General Brigham, Blue Circle Health. Funding source: Leona M. and Harry B. Helmsley Charitable Trust.
Disclosure(s):Monica Gomberg, MD: No financial relationships to disclose
Learn more about Blue Circle Health here.
